PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy

Completed · Phase 1

Conditions studied: Vitrectomy

In brief

The purpose of this study is to evaluate the pharmacokinetics (PK) of dexamethasone phosphate ophthalmic solution delivered via the EyeGate® II Drug Delivery System (EGDS) in patients undergoing vitrectomy for macular hole repair or epiretinal membrane peeling

Key facts

Study ID

NCT02644694

Run by

Eyegate Pharmaceuticals, Inc.

People needed

10

Starts

2016-03-01

Expected to finish

2016-11-01

Last updated by the study team

2017-02-07

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 to 85 years
• Receive, understand, and sign a copy of the written informed consent form

Where it is running

• Ophthalmic Consultants of Boston — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.